Delta 4 GmbH

Austria


Create a watch for Delta 4 GmbH
Total IP 13
Total IP Rank # 120,346
IP Activity Score 2/5.0    14
IP Activity Rank # 61,189
Dominant Nice Class Scientific and electric apparatu...

Patents

Trademarks

4 0
2 0
5 0
2
 
Last Patent 2024 - Genistein for use in the treatme...
First Patent 2021 - Antiviral use of liraglutide and...
Last Trademark 2024 - Hyper-C
First Trademark 2024 - Hyper-C

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 G/S Software. Provision of information relating to media communications. Updating of computer programs.
G/S Software; Unified communications software. Information relating to communications. Updating of co...
2023 Invention Novel use of glucagon-like peptide 1 (glp-1) agonist. The present invention refers to the new use...
2021 Invention Genistein for use in the treatment of focal segmental glomerulosclerosis (fsgs). The present inv...
Invention Saroglitazar and myristic acid for use in the treatment of focal segmental glomerulosclerosis (fs...
Invention Clopidogrel for use in the treatment of focal segmental glomerulosclerosis (fsgs). The present i...
Invention Genistein for use in the treatment of focal segmental glomerulosclerosis (fsgs). The present inve...
Invention Clopidogrel for use in the treatment of focal segmental glomerulosclerosis (fsgs). The present in...
Invention Antiviral use of liraglutide and gefitinib. The present invention refers to a pharmaceutical pre...
Invention Antiviral use of liraglutide and gefitinib. The present invention refers to a pharmaceutical prep...